Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.

Phospholipase A2 (PLA2) participates in a wide range of cellular processes including inflammation and transmembrane signaling. A human nonpancreatic secretory PLA2 (hnps-PLA2) has been identified that is found in high concentrations in the synovial fluid of patients with rheumatoid arthritis and in the plasma of patients with septic shock. This enzyme is secreted from certain cell types in response to the proinflammatory cytokines, tumor necrosis factor or interleukin-1. The crystal structures of the calcium-bound form of this enzyme have been determined at physiological pH both in the presence [2.1 angstrom (A) resolution] and absence (2.2 A resolution) of a transition-state analogue. Although the critical features that suggest the chemistry of catalysis are identical to those inferred from the crystal structures of other extracellular PLA2s, the shape of the hydrophobic channel of hnps-PLA2 is uniquely modulated by substrate binding.

[1]  D. R. Holland,et al.  The crystal structure of a lysine 49 phospholipase A2 from the venom of the cottonmouth snake at 2.0-A resolution. , 1994, The Journal of biological chemistry.

[2]  D. Clawson,et al.  Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 Å resolution , 1991, Nature.

[3]  P. Lawton,et al.  Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints. , 1991, Journal of immunology.

[4]  H. Arita,et al.  Intracellular localization of group II phospholipase A2 in rat vascular smooth muscle cells and its possible relationship to eicosanoid formation. , 1991, Biochimica et biophysica acta.

[5]  M. Gelb,et al.  Interfacial catalysis: the mechanism of phospholipase A2 , 1990, Science.

[6]  M. Gelb,et al.  Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue , 1990, Science.

[7]  H. Arita,et al.  Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid , 1990, FEBS letters.

[8]  K. H. Kalk,et al.  X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor , 1990, Nature.

[9]  J. D. Clark,et al.  Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Gelb,et al.  Kinetic and inhibition studies of phospholipase A2 with short-chain substrates and inhibitors. , 1990, Biochemistry.

[11]  C. Schalkwijk,et al.  Studies on the acyl-chain selectivity of cellular phospholipases A2. , 1990, Biochimica et biophysica acta.

[12]  H. Tojo,et al.  The primary structure of a membrane-associated phospholipase A2 from human spleen. , 1989, Biochemical and biophysical research communications.

[13]  P. Vadas,et al.  Multiple forms of phospholipase A2 in arthritic synovial fluid. , 1989, Journal of biochemistry.

[14]  D. Smith,et al.  Characterisation of soluble and cell associated phospholipase A2 from rheumatoid synovial fluid. , 1989, Annals of the rheumatic diseases.

[15]  R. Kramer,et al.  Structure and properties of a human non-pancreatic phospholipase A2. , 1989, The Journal of biological chemistry.

[16]  W Pruzanski,et al.  Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. , 1989, The Journal of biological chemistry.

[17]  G. Hughes,et al.  Synovial fluid phospholipase A2s and inflammation. , 1989, Annals of the rheumatic diseases.

[18]  H. Verheij,et al.  The role of Asp‐49 and other conserved amino acids in phospholipases A2 and their importance for enzymatic activity , 1989, Journal of cellular biochemistry.

[19]  A. Joachimiak,et al.  Crystal structure of trp represser/operator complex at atomic resolution , 1988, Nature.

[20]  K. Inoue,et al.  Amino acid composition and NH2-terminal amino acid sequence of human phospholipase A2 purified from rheumatoid synovial fluid. , 1988, Journal of biochemistry.

[21]  P. Fitzgerald MERLOT, an integrated package of computer programs for the determination of crystal structures by molecular replacement , 1988 .

[22]  M. Gelb,et al.  Phosphonate-containing phospholipid analogues as tight-binding inhibitors of phospholipase-A2 , 1988 .

[23]  E. Dennis Regulation of Eicosanoid Production: Role of Phospholipases and Inhibitors , 1987, Bio/Technology.

[24]  J. Musser,et al.  Phospholipase A2: function and pharmacological regulation. , 1987, Biochemical pharmacology.

[25]  B. Finzel Incorporation of fast Fourier transforms to speed restrained least‐squares refinement of protein structures , 1987 .

[26]  M. Karplus,et al.  Crystallographic R Factor Refinement by Molecular Dynamics , 1987, Science.

[27]  P. Vadas,et al.  Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritis. , 1986, Journal of biochemistry.

[28]  P. Vadas,et al.  Role of secretory phospholipases A2 in the pathobiology of disease. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[29]  P B Sigler,et al.  The refined crystal structure of dimeric phospholipase A2 at 2.5 A. Access to a shielded catalytic center. , 1986 .

[30]  P. Vadas,et al.  Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits. , 1986, The Journal of investigative dermatology.

[31]  F. Snyder Chemical and biochemical aspects of platelet activating factor: A novel class of acetylated ether‐linked choline‐phospholipids , 1985, Medicinal research reviews.

[32]  W G Hol,et al.  Structure of porcine pancreatic phospholipase A2 at 2.6 A resolution and comparison with bovine phospholipase A2. , 1983, Journal of molecular biology.

[33]  R. Irvine How is the level of free arachidonic acid controlled in mammalian cells? , 1982, The Biochemical journal.

[34]  W. Hol,et al.  Structure of bovine pancreatic phospholipase A2 at 1.7A resolution. , 1981, Journal of molecular biology.

[35]  E. Dennis,et al.  Phospholipase A2 contamination of cobra venom factor preparations. Biologic role in complement-dependent in vivo reactions and inactivation with p-bromophenacyl bromide. , 1978, The American journal of pathology.

[36]  R. Verger,et al.  Further studies of mode of action of lipolytic enzymes. , 1977, The Journal of biological chemistry.

[37]  J. Vidal,et al.  Zymogen-catalyzed hydrolysis of monomeric substrates and the presence of a recognition site for lipid-water interfaces in phospholipase A2. , 1974, Biochemistry.

[38]  M. Lazdunski,et al.  Zymogen-enzyme transformations. On the mechanism of activation of prophospholipase A. , 1972, European journal of biochemistry.

[39]  R. A. Crowther,et al.  A method of positioning a known molecule in an unknown crystal structure , 1967 .

[40]  P. Sigler,et al.  Facing up to membranes: structure/function relationships in phospholipases. , 1987, Cold Spring Harbor symposia on quantitative biology.